Analyze up to 5000 proteins with just 2ul of samples
Discover novel biological insights by analyzing 1000s of proteins with High-Plex technologies powered by NGS!
Trusted by:
What is High-Plex Protein Analysis?
High-Plex Protein Analysis refers to the simultaneous analysis of 100s to 1000s of proteins providing a comprehensive view of the protein landscape.
The emergence of oligonucleotide-labeling of antibodies has enabled NGS technologies to be used in protein research and led to new levels of multiplexing.
The new High-Plex Protein technologies based on NGS have allowed unprecedented quality, speed, sensitivity, specificity, and proteome coverage.
You can now discover important biological mechanisms and focus on novel biological insights.
Why invest in a High-Plex protein analysis?
Take your research to the next level.
Deep Biological Insights:
Get a comprehensive view of the protein landscape and reveal protein mechanisms and new biological insights.
Biomarker Discovery:
Identify new proteins for early disease detection, prognosis, or prediction of treatment options.
Cost-Effectiveness in focused panels:
Design new focused panels with the truly important proteins of interest.
Drug Development and Validation:
Identify proteins affected by drugs or validate drug effects on multiple proteins.
Personalized Medicine:
Profile individual patients’ protein expression patterns that guide treatment decisions and predict responses to specific interventions.
Publication Impact:
High-Plex studies often generate comprehensive datasets that can lead to impactful publications, advancing the field and contributing to scientific knowledge.
Competitive Edge:
In research and pharmaceutical industries, staying at the forefront of technology can provide a competitive advantage. High-Plex analysis allows you to harness cutting-edge tools to answer complex research questions.
How we work
Study design
Instead of merely analyzing samples, we provide you with a dedicated proteomic specialist who possesses extensive knowledge and ensures that the study design is tailored to your specific requirements. We strive to understand every aspect of your needs, ranging from sample testing and discovery expectations to multi-omics analysis for biological insights, clinical evaluations, regulatory coverage, IP strategies, on-site training, and even successful commercialization either as RUO, LDT, or IVD.
The Team
Leonidas Alexopoulos
co-founder & CSO, Professor, National Technical University of Athens
Leonidas was one of the pioneers of multiplex assays with more than 20 years of experience. He has studied at Duke, MIT and Harvard. He is currently a full professor at the National Technical University of Athens
Leonidas Alexopoulos
co-founder & CSO, Professor, National Technical University of Athens
Leonidas was one of the pioneers of multiplex assays with more than 20 years of experience. He has studied at Duke, MIT and Harvard. He is currently a full professor at the National Technical University of Athens
Leonidas Alexopoulos
co-founder & CSO, Professor, National Technical University of Athens
Leonidas was one of the pioneers of multiplex assays with more than 20 years of experience. He has studied at Duke, MIT and Harvard. He is currently a full professor at the National Technical University of Athens
Protavio Ltd Copyright 2023. All Rights Reserved
Privacy Policy Terms & Conditions